Using smartphone data to help diagnose Alzheimer's disease
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
NA · Poitiers University Hospital · NCT05709210
This study is trying to see if tracking how people use their smartphones can help doctors diagnose Alzheimer's disease earlier in patients with memory problems.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Poitiers University Hospital (other) |
| Locations | 1 site (Poitiers) |
| Trial ID | NCT05709210 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to explore the feasibility of using smartphone usage data as a diagnostic marker for Alzheimer's disease (AD) by comparing data from three groups: patients with memory complaints, those with mild cognitive impairment (MCI), and individuals diagnosed with AD. The study will involve 90 patients, with data collected over three months to identify differences in smartphone usage patterns that may correlate with cognitive status. The hypothesis is that changes in smartphone usage could indicate a progression towards AD, potentially allowing for earlier diagnosis and intervention.
Who should consider this trial
Good fit: Ideal candidates include patients with memory complaints, mild cognitive decline, or a diagnosis of Alzheimer's disease who are consulting in routine care.
Not a fit: Patients with other neurodegenerative conditions or severe mental health disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of Alzheimer's disease, improving patient outcomes.
How similar studies have performed: While the use of smartphone data in medical diagnostics is an emerging field, this specific approach to diagnosing Alzheimer's disease is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient consulting in routine care in one of the CMRR * No sensory impairment that may compromise smartphone use Exclusion Criteria: * Inability to perform MMSE or MMSE \< 20 ; * Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis) * Severe anxiety or depressive disorder HADS score ≥ 17 * Terminal phase of a severe disease * Evidence of a lesion on MRI that may be involved in cognitive impairment
Where this trial is running
Poitiers
- CHU Poitiers — Poitiers, France (RECRUITING)
Study contacts
- Study coordinator: Adrien JULIAN
- Email: adrien.julian@chu-poitiers.fr
- Phone: +33(0)549444444
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alzheimer Disease, Memory Disorders, Smartphone